A study suggests immunotherapy has extended the lives of some patients with triple negative breast cancer, the most aggressive form of the disease.
USA TODAY, Cincinnati Enquirer
Mon, 10/22/2018 - 5:00am
A study suggests immunotherapy has extended the lives of some patients with triple negative breast cancer, the most aggressive form of the disease.